Ferry Ossendorp Selected Research

AGP 527

6/2022

Lipid A analog CRX-527 conjugated to synthetic peptides enhances vaccination efficacy and tumor control.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ferry Ossendorp Research Topics

Disease

92	Neoplasms (Cancer) 01/2024 - 01/2002
7	Melanoma (Melanoma, Malignant) 06/2022 - 01/2011
5	Colonic Neoplasms (Colon Cancer) 01/2023 - 01/2019
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2019
3	Experimental Melanoma 01/2019 - 08/2009
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2011 - 12/2005
2	Inflammation (Inflammations) 10/2022 - 03/2014
2	Infections 01/2022 - 09/2002
2	Dehydration (Water Stress) 09/2018 - 12/2011
2	Tetanus 01/2018 - 01/2018
2	Leukemia 07/2003 - 10/2002
1	Hematologic Neoplasms (Hematological Malignancy) 01/2024
1	Bites and Stings (Sting) 01/2023
1	Pathologic Complete Response 01/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2022
1	Necrosis 01/2022
1	COVID-19 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020
1	Breast Neoplasms (Breast Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

24	Peptides (Polypeptides)IBA 10/2022 - 10/2002
22	AntigensIBA 01/2024 - 01/2002
19	VaccinesIBA 01/2024 - 10/2002
13	EpitopesIBA 11/2022 - 01/2002
12	AntibodiesIBA 07/2023 - 03/2012
10	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2022 - 03/2016
8	LigandsIBA 10/2022 - 01/2012
7	Liposomes (Liposome)IBA 08/2023 - 12/2011
6	Immunoglobulin G (IgG)IBA 01/2019 - 04/2006
5	Immune Checkpoint InhibitorsIBA 07/2023 - 01/2017
5	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 04/2013
5	Cancer VaccinesIBA 01/2019 - 04/2015
4	Photosensitizing Agents (Photosensitizers)IBA 06/2022 - 03/2016
4	CytokinesIBA 01/2022 - 04/2013
4	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2021 - 07/2003
4	Proteins (Proteins, Gene)FDA Link 12/2019 - 01/2011
4	Antigen-Antibody Complex (Immune Complex)IBA 01/2018 - 04/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2019
3	OvalbuminIBA 01/2022 - 01/2018
3	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2022 - 08/2014
3	Blocking AntibodiesIBA 11/2020 - 01/2017
3	Protein Subunit VaccinesIBA 01/2017 - 04/2013
3	Insulin (Novolin)FDA Link 11/2011 - 12/2005
2	ChemokinesIBA 01/2023 - 01/2019
2	atezolizumabIBA 01/2023 - 11/2020
2	InterferonsIBA 01/2023 - 02/2015
2	Toll-Like Receptor 2IBA 10/2022 - 10/2016
2	Polylactic Acid-Polyglycolic Acid CopolymerIBA 10/2020 - 01/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2020 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 03/2016
2	Monoclonal AntibodiesIBA 01/2020 - 03/2016
2	NanogelsIBA 12/2019 - 12/2016
2	Amino Acids FDA Link 01/2019 - 10/2002
2	Therapeutic UsesIBA 12/2018 - 03/2016
2	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2018 - 06/2014
2	Poly I-CIBA 01/2017 - 12/2016
2	Monatide (IMS 3015)IBA 03/2016 - 03/2014
2	I-antigenIBA 02/2016 - 11/2014
2	AutoantigensIBA 02/2016 - 01/2002
2	Delayed-Action PreparationsIBA 06/2014 - 10/2013
2	Minor Histocompatibility AntigensIBA 07/2003 - 10/2002
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 08/2023
1	cabozantinibIBA 08/2023
1	Drug CombinationsIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023
1	Docetaxel (Taxotere)FDA Link 01/2023
1	Chemokine ReceptorsIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Pemetrexed (MTA)FDA Link 01/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023
1	Granzymes (Granzyme)IBA 01/2023
1	Natural Killer Cell ReceptorsIBA 01/2023
1	MHC class II transactivator proteinIBA 10/2022
1	Lipid AIBA 06/2022
1	AGP 527IBA 06/2022
1	Drug CarriersIBA 06/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2022
1	Zn(II)-phthalocyanine (zinc phthalocyanine)IBA 09/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Conjugate VaccinesIBA 10/2020
1	LipidsIBA 10/2020
1	HydrogelsIBA 10/2020
1	Antineoplastic Agents (Antineoplastics)IBA 10/2020
1	MicellesIBA 05/2020
1	Trastuzumab (Herceptin)FDA Link 01/2020
1	DNA VaccinesIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019

Therapy/Procedure

42	Immunotherapy 08/2023 - 01/2002
35	Therapeutics 01/2024 - 10/2008
11	Photochemotherapy (Photodynamic Therapy) 06/2022 - 03/2016
10	Drug Therapy (Chemotherapy) 01/2023 - 04/2013
3	Immunomodulation 11/2020 - 11/2013
2	Aftercare (After-Treatment) 10/2020 - 03/2016
2	Fluid Therapy (Oral Rehydration Therapy) 09/2018 - 12/2011
1	Intradermal Injections 06/2022
1	Phototherapy (Light Therapy) 11/2020
1	Radiotherapy 11/2020